P. Lio, “Real World Baseline Characteristics and Early Patient Reported Outcomes in Adult Patients with Moderate to Severe Atopic Dermatitis Treated with Tralokinumab”, J of Skin, vol. 7, no. 2, p. s145, Mar. 2023.